The dermal‐epidermal junction consists of a network of several interacting structural
proteins that strengthen adhesion and mediate signalling events. This structural network …

Bullous systemic lupus erythematosus (BSLE) is a rare cutaneous complication of systemic
lupus erythematosus (SLE). It is a heterogeneous disease that is caused by autoantibodies …

Cutaneous lupus erythematosus (CLE) is a rare inflammatory autoimmune disease with
heterogeneous clinical manifestations. To date, no therapeutic agents have been licensed …

Background Bullous systemic lupus erythematosus (BSLE) is a rare blistering condition
associated with systemic lupus erythematosus (SLE). Patients and methods We conducted a …

Bullous systemic lupus erythematosus (BSLE) is an autoantibody‐mediated vesiculobullous
disease in patients with SLE. Autoimmunity in BSLE is characterized by the presence of …

Background: A variety of therapeutic options have been reported for cutaneous lupus
erythematosus (CLE); one of these is dapsone. However, no high priority has been given to …

SWD, IgA pemphigus, and BSLE are rare diseases with overlapping clinical and
pathophysiological features, highlighting the spectral nature of neutrophilic dermatoses and …

Neutrophilic figurate erythema of infancy (NFEI) is a rare variant of annular erythema of
infancy. It is characterized by annular erythematous plaques, occasionally with a polycyclic …

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that affects multiple
systems in the body. The disease is characterized by a wide range of cutaneous …

Bullous eruptions in patients with lupus erythematosus can be difficult to diagnose as
bullous lesions can develop in lupus-specific lesions, and primary blistering disorders can …